<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00114504</url>
  </required_header>
  <id_info>
    <org_study_id>KurumeU-2416</org_study_id>
    <nct_id>NCT00114504</nct_id>
  </id_info>
  <brief_title>Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation</brief_title>
  <official_title>Detection of Atherosclerotic Plaque Inflammation and Visualization of Anti-inflammatory Effects of Statins on Plaque Inflammation by FDG-PET</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kurume University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kurume University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether FDG-PET is capable of detecting
      atherosclerotic plaque inflammation and monitoring the effects of statins on plaque
      inflammation. The usefulness of FDG-PET in risk stratification is also investigated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is increasing evidence that inflammation plays a role in progression and
      destabilization of atherosclerotic plaque. However, currently, no non-invasive method is
      available for detecting plaque inflammation in clinical practice. FDG-PET can visualize
      activated metabolic levels of not only tumor cells but also inflammatory cells. Thus, it is
      possible that FDG-PET can detect atherosclerotic plaque inflammation and that, if so, FDG-PET
      can monitor the direct effect of statins on plaque inflammation. Additionally, monitoring the
      plaque inflammation by FDG-PET may be useful for determining the risk stratification of
      atherosclerotic patients.

      Originally, we sought to compare patients with FDG-positive plaque with patients with plaque
      but not with FDG uptake, patients with FDG-positive plaque receiving statin therapy, and
      patients with FDG-positive plaque receiving diet management therapy. However, because patient
      number enrolled in the study was too small, the comparison was performed between FDG-positive
      patients with and without any statin therapy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2004</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plaque Inflammation</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>Change in plaque inflammation was assessed by changes in the plaque SUV.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Circulating Inflammation Marker</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>Change in circulating hsCRP levels</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Simvastatin group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with FDG-positive plaque who received simvastatin and diet therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients FDG-positive plaque who received diet therapy alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>simvastatin</intervention_name>
    <description>simvastatin 5-10 mg/day</description>
    <arm_group_label>Simvastatin group</arm_group_label>
    <other_name>control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Protocol 1: patients who had carotid atherosclerosis detected by carotid ultrasound.

          -  Protocol 2: patients who underwent FDG-PET for cancer screening and had vascular FDG
             uptakes

        Exclusion Criteria:

          -  Active inflammatory diseases

          -  Dyslipidemia under medications

          -  Uncontrolled diabetes mellitus, vasculitis, symptomatic coronary artery disease,
             symptomatic cerebrovascular diseases

          -  Known systemic disorders such as hepatic, renal, hematopoietic, and malignant diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hisashi Kai, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Third Department of Internal Medicine, Kurume University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kurume University Hospital</name>
      <address>
        <city>Kurume</city>
        <zip>830-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2005</study_first_submitted>
  <study_first_submitted_qc>June 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2005</study_first_posted>
  <results_first_submitted>March 31, 2015</results_first_submitted>
  <results_first_submitted_qc>May 13, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 1, 2015</results_first_posted>
  <last_update_submitted>May 13, 2015</last_update_submitted>
  <last_update_submitted_qc>May 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kurume University</investigator_affiliation>
    <investigator_full_name>Hisashi Kai</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>atherosclerosis</keyword>
  <keyword>inflammation</keyword>
  <keyword>statins</keyword>
  <keyword>PET</keyword>
  <keyword>carotid ultrasonography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Simvastatin Group</title>
          <description>Patients with FDG-positive carotid artery and/or aorta who received simvastatin and diet therapy</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>Patients with FDG-positive carotid artery and/or aorta who received diet therapy alone</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Simvastatin Group</title>
          <description>Patients with FDG-positive carotid artery and/or aorta who received simvastatin and diet therapy</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>Patients with FDG-positive carotid artery and/or aorta who received diet therapy alone</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="43"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65" spread="9"/>
                    <measurement group_id="B2" value="62" spread="6"/>
                    <measurement group_id="B3" value="63" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Japanese</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Japanese</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Japan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Plaque Inflammation</title>
        <description>Change in plaque inflammation was assessed by changes in the plaque SUV.</description>
        <time_frame>Baseline, 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Simvastatin Group</title>
            <description>Patients with FDG-positive carotid artery and/or aorta who received simvastatin and diet therapy for 3 months</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Patients with FDG-positive carotid artery and/or aorta who received diet therapy alone or 3 months</description>
          </group>
        </group_list>
        <measure>
          <title>Plaque Inflammation</title>
          <description>Change in plaque inflammation was assessed by changes in the plaque SUV.</description>
          <units>SUV</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.59" spread="0.22"/>
                    <measurement group_id="O2" value="1.63" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Circulating Inflammation Marker</title>
        <description>Change in circulating hsCRP levels</description>
        <time_frame>Baseline, 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Simvastatin Group Baseline</title>
            <description>Patients with FDG-positive carotid artery and/or aorta who received simvastatin and diet therapy at baseline</description>
          </group>
          <group group_id="O2">
            <title>Simvastatin Group at 3 Month</title>
            <description>Patients with FDG-positive carotid artery and/or aorta who received simvastatin and diet therapy for 3 months</description>
          </group>
          <group group_id="O3">
            <title>Control Group Baseline</title>
            <description>Patients with FDG-positive carotid artery and/or aorta who received diet therapy alone at baseline</description>
          </group>
          <group group_id="O4">
            <title>Control Group at 3 Months</title>
            <description>Patients with FDG-positive carotid artery and/or aorta who received diet therapy alone for 3 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Circulating Inflammation Marker</title>
          <description>Change in circulating hsCRP levels</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.11"/>
                    <measurement group_id="O2" value="0.06" spread="0.07"/>
                    <measurement group_id="O3" value="0.11" spread="0.16"/>
                    <measurement group_id="O4" value="0.07" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Simvastatin Group</title>
          <description>Patients with FDG-positive carotid artery and/or aorta who received simvastatin and diet therapy</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>Patients with FDG-positive carotid artery and/or aorta who received diet therapy alone</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Hisashi Kai</name_or_title>
      <organization>Kurume University</organization>
      <phone>+81-942-31-7562</phone>
      <email>naikai@med.kurume-u.ac.jp</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

